Charles River Laboratories | CRL - Umlaufvermögen

Aktienkurs
169.80
Täglich Wechseln
2.06 1.23%
Monatlich
2.36%
Jährlich
48.09%
Q2 Prognose
166.17




Umlaufvermögen Veränderung Datum
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Cardinal Health USD 39.23B 693M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cigna USD 47.81B 1.08B 2025-12
Concord Medical Services Hldg CNY 1.03B 174.49M 2025-06
CVS Health USD 74.71B 2.4B 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
Elevance Health USD 67.03B 4.03B 2026-03
Galapagos EUR 3.08B 82.56M 2025-12
Humana USD 32.73B 19M 2025-12
Illumina USD 3.29B 493M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Lonza CHF 8B 3.41B 2025-12
McKesson USD 59.7B 190M 2025-12
Merck EUR 13.23B 354M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Quest Diagnostics USD 2.57B 188M 2026-03
Revvity USD 2.24B 95.96M 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
United Therapeutics USD 3.7B 208.5M 2025-12
UnitedHealth USD 90.58B 4.49B 2025-12
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.83B 151.4M 2026-03